ICU Medical, Inc. (ICUI) Stock Forecast & Price Target

ICU Medical, Inc. (ICUI) has an ST Score of 49.8 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Wall Street's consensus rating on ICUI is Buy based on 12 analyst ratings. Our own ST Score grades it C+ (49.8/100). This is data, not investment advice — always do your own research.

ICU Medical, Inc. (ICUI) earns a valuation grade of C+, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

ICU Medical, Inc. (ICUI) earns a growth grade of C, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

ICU Medical, Inc. (ICUI) earns a profitability grade of C, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

ICU Medical, Inc. (ICUI) earns a financial strength grade of D+, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for ICU Medical, Inc. (ICUI) is $186.40 from 12 analysts, which is +0.2% versus the recent price of $152.65.

ICU Medical, Inc. (ICUI) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.